Nfe2l3−/− mice exhibit significantly less inflammation in the colon, reduced tumor size and numbers; NFE2L3 deficiency disrupts mast cell homeostasis via downregulation of Il33 and Rab27a. Here, IL33 is linked to neoplasm.